inflammation; atherosclerose; ASCVD; IL-6; colchicine

Peter Libby presents the role of inflammation in ASCVD

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Perspectives on CKM syndrome
Perspectives on CKM syndrome
AHA 2024
Perspectives on CKM syndrome
- Javed Butler, MD
Exciting times to address residual inflammatory risk
Exciting times to address residual inflammatory risk
EAS 2024
Exciting times to address residual inflammatory risk
- Peter Libby, MD
Anti-inflammatory therapies for CVD risk prevention
Anti-inflammatory therapies for CVD risk prevention
EAS 2024
Anti-inflammatory therapies for CVD risk prevention
- Ulrich Laufs, MD, PhD
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
ESC Congress 2023
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
- Stephen Nicholls, MD